Grantham, Mayo, Van Otterloo & Co (GMO)
CI icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Cigna CI Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CI Stock Details CI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$710M Sell
2,577,075
-21,143
-0.8% -$5.97M 1.6% 21
2026
Q1 		$693M Buy
2,598,218
+640,084
+33% +$177M 1.77% 18
2025
Q4 		$539M Buy
1,958,134
+323,786
+20% +$90.8M 1.38% 25
2025
Q3 		$471M Buy
1,634,348
+90,370
+6% +$26.7M 1.33% 28
2025
Q2 		$510M Sell
1,543,978
-44,885
-3% -$14.5M 1.54% 24
2025
Q1 		$523M Buy
1,588,863
+110,096
+7% +$33.2M 1.65% 23
2024
Q4 		$408M Buy
1,478,767
+55,839
+4% +$17.8M 1.33% 26
2024
Q3 		$493M Buy
1,422,928
+299,009
+27% +$103M 1.55% 23
2024
Q2 		$372M Buy
1,123,919
+135,980
+14% +$46.9M 1.25% 26
2024
Q1 		$359M Buy
987,939
+277,165
+39% +$91.2M 1.3% 25
2023
Q4 		$213M Buy
710,774
+24,678
+4% +$7.21M 0.94% 30
2023
Q3 		$196M Buy
686,096
+41,048
+6% +$11.7M 0.93% 29
2023
Q2 		$181M Buy
645,048
+126,102
+24% +$32.8M 0.84% 32
2023
Q1 		$133M Sell
518,946
-48,805
-9% -$14.2M 0.67% 36
2022
Q4 		$188M Sell
567,751
-125,810
-18% -$39.8M 1% 26
2022
Q3 		$192M Sell
693,561
-16,706
-2% -$4.7M 1.11% 23
2022
Q2 		$187M Sell
710,267
-110,127
-13% -$28.4M 1.01% 25
2022
Q1 		$197M Sell
820,394
-15,753
-2% -$3.69M 0.95% 26
2021
Q4 		$192M Sell
836,147
-18,876
-2% -$4.01M 0.92% 28
2021
Q3 		$171M Buy
855,023
+198,742
+30% +$43.2M 0.85% 31
2021
Q2 		$156M Buy
656,281
+39,254
+6% +$9.8M 0.78% 30
2021
Q1 		$149M Buy
617,027
+536,363
+665% +$120M 0.81% 32
2020
Q4 		$16.8M Buy
+80,664
New +$15.8M 0.1% 140
2019
Q1 		– Sell
-4,690
Closed -$891K – 703
2018
Q4 		$891K Buy
+4,690
New +$978K 0.01% 366
2016
Q2 		– Sell
-1,800
Closed -$247K – 576
2016
Q1 		$247K Sell
1,800
-549,900
-100% -$75.5M ﹤0.01% 528
2015
Q4 		$80.7M Buy
551,700
+106,810
+24% +$14.7M 0.29% 71
2015
Q3 		$60.1M Buy
444,890
+443,090
+24,616% +$64.3M 0.21% 96
2015
Q2 		$292K Sell
1,800
-400
-18% -$55.3K ﹤0.01% 412
2015
Q1 		$285K Hold
2,200
– – ﹤0.01% 404
2014
Q4 		$226K Sell
2,200
-500
-19% -$49.3K ﹤0.01% 430
2014
Q3 		$245K Sell
2,700
-2,300
-46% -$215K ﹤0.01% 423
2014
Q2 		$460K Sell
5,000
-75,000
-94% -$6.43M ﹤0.01% 443
2014
Q1 		$6.7M Sell
80,000
-74,352
-48% -$6.12M 0.02% 246
2013
Q4 		$13.5M Buy
154,352
+39,100
+34% +$3.2M 0.03% 181
2013
Q3 		$8.86M Sell
115,252
-20,684
-15% -$1.62M 0.02% 224
2013
Q2 		$9.85M Buy
+135,936
New +$9.16M 0.03% 206

Other funds holding CI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CI Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Cigna (CI) stake by 0.81% in Q2 2026, selling an estimated $5.97M and leaving 2,577,075 shares worth $710M. The position accounts for 1.6% of the portfolio, ranked #21.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CI in Q2 2013 and has held it in 36 quarters since. 1,694 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 2,577,075 shares of Cigna worth $710M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 21,143 Cigna shares in Q2 2026, an estimated $5.97M.
  • Cigna made up 1.6% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #21 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cigna in Q2 2013 and has held it in 36 quarters since.
  • 1,694 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.